000			01592 a2200457 4500
005			20250515115549.0
264		0	_c20080707
008			200807s 0 0 eng d
022			_a1521-7035
024	7		_a10.1016/j.clim.2008.02.009 _2doi
040			_aNLM _beng _cNLM
100	1		_aYu, Qi T
245	0	0	_aVisilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways. _h[electronic resource]
260			_bClinical immunology (Orlando, Fla.) _cJun 2008
300			_a322-9 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _ximmunology
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aApoptosis
650	0	4	_aApoptosis Regulatory Proteins _ximmunology
650	0	4	_aCD3 Complex _ximmunology
650	0	4	_aCaspase 3 _xmetabolism
650	0	4	_aCaspase 8 _xmetabolism
650	0	4	_aCells, Cultured
650	0	4	_aColitis, Ulcerative _ximmunology
650	0	4	_aEnzyme Inhibitors _ximmunology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIntestinal Mucosa _ximmunology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMucous Membrane _ximmunology
650	0	4	_aT-Lymphocytes _xdrug effects
700	1		_aSaruta, Masayuki
700	1		_aPapadakis, Konstantinos A
773	0		_tClinical immunology (Orlando, Fla.) _gvol. 127 _gno. 3 _gp. 322-9
856	4	0	_uhttps://doi.org/10.1016/j.clim.2008.02.009 _zAvailable from publisher's website
999			_c17921735 _d17921735